Outcome of patients treated with pentostatin as salvage therapy of steroid refractory acute intestinal graft-versus-host disease

被引：0

作者：

Klein, SA ^{[1
]}

Bug, G ^{[1
]}

Wassmann, B ^{[1
]}

Hoelzer, D ^{[1
]}

Martin, H ^{[1
]}

机构：

[1] Univ Frankfurt Klinikum, D-6000 Frankfurt, Germany

来源：

BONE MARROW TRANSPLANTATION | 2004年 / 33卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S180 / S180

页数：1

共 50 条

[31] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
Kyohei Isshiki
Takahiro Kamiya
Akifumi Endo
Kentaro Okamoto
Tomoo Osumi
Toshinao Kawai
Katsuhiro Arai
Daisuke Tomizawa
Kazuo Ohtsuka
Masakazu Nagahori
Kohsuke Imai
Motohiro Kato
Hirokazu Kanegane
International Journal of Hematology, 2022, 115 : 590 - 594
[32] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
Isshiki, Kyohei
Kamiya, Takahiro
Endo, Akifumi
Okamoto, Kentaro
Osumi, Tomoo
Kawai, Toshinao
Arai, Katsuhiro
Tomizawa, Daisuke
Ohtsuka, Kazuo
Nagahori, Masakazu
Imai, Kohsuke
Kato, Motohiro
Kanegane, Hirokazu
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 590 - 594
[33] Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease
Melgarejo-Ortuno, Alejandra
Escudero-Vilaplana, Vicente
Luis Revuelta, Jose
Bailen, Rebeca
Collado-Borrell, Roberto
Gomez-Centurion, Ignacio
Oarbeascoa, Guillen
Kwon, Mi
Heranz, Ana
Luis Diez-Martin, Jose
Sanjurjo, Maria
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 751 - 755
[34] Intra-arterial steroid therapy for steroid refractory graft-versus-host disease
Madeira, MI
Favarin, MC
Pieroni, F
Stracieri, AB
Oliveira, MC
Moraes, D
Voltarelli, JC
Simoes, BP
BONE MARROW TRANSPLANTATION, 2006, 37 : S98 - S99
[35] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
Namdaroglu, S.
Iskender, D.
Dal, M. S.
Cakar, M. K.
Tekgunduz, E.
Altuntas, F.
HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
[36] Pentostatin Therapy for Steroid-Refractory Acute Graft Versus Host Disease: Identifying Those Who May Benefit
Ragon, Brittany Knick
Gulbis, Alison M.
Saliba, Rima M.
Chen, Julianne
Rondon, Gabriela
Popat, Uday R.
Nieto, Yago
Oran, Betul
Olson, Amanda L.
Patel, Krina
Hosing, Chitra M.
Qazilbash, Muzaffar H.
Shah, Nina
Kebriaei, Partow
Shpall, Elizabeth J.
Champlin, Richard E.
Alousi, Amin M.
BLOOD, 2015, 126 (23)
[37] Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease
Sanchez-Ortega, Isabel
Servitje, Octavio
Arnan, Montserrat
Orti, Guillermo
Peralta, Teresa
Manresa, Federico
Duarte, Rafael F.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 318 - 323
[38] Daclizumab therapy improves outcome in steroid refractory acute graft versus host disease (aGVHD).
Doocey, RT
Greenwood, MJ
Warkentin, D
Song, KW
Le, A
Nitta, J
Nevill, TJ
Barnett, MJ
Forrest, DL
Hogge, DE
Lavoie, JC
Nantel, SH
Shepherd, JD
Sutherland, HJ
Toze, CL
Smith, CA
BLOOD, 2004, 104 (11) : 356B - 356B
[39] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
Gomez-Almaguer, David
Ruiz-Arguelles, Guillermo
Gonzalez-Llano, Oscar
Cantu, Olga G.
Gutierrez, Cesar H.
Jaime-Perez, Jose Carlos
Tarin-Arzaga, Luz
Giralt, Sergio
BLOOD, 2006, 108 (11) : 415B - 416B
[40] Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
Pidala, Joseph
Kim, Jongphil
Field, Teresa
McBride, Ali
Kharfan-Dabaja, Mohamed
Perkins, Janelle
Fernandez, Hugo
Perez, Lia
Ayala, Ernesto
Anasetti, Claudio
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1116 - 1121

← 1 2 3 4 5 →